A peptide (CREKA) identified by phage display was fused to tTF, and found to be effective at causing intratumoral thrombosis and inhibition of tumor growth in hepatocellular colon and breast cancer models at significantly lower doses relative to other thrombogenic constructs. This evidence concerns the gene RHOH and breast carcinoma.